Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.70
+0.12 (0.95%)
At close: Mar 9, 2026, 4:00 PM EDT
12.70
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:10 PM EDT

Entrada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Net Income
-143.7565.63-6.69-94.62-51.16
Upgrade
Depreciation & Amortization
4.13.772.841.91.12
Upgrade
Loss (Gain) From Sale of Assets
----0.07
Upgrade
Loss (Gain) From Sale of Investments
-3.67-10.02-5.780.15-
Upgrade
Stock-Based Compensation
19.6117.9213.119.92.53
Upgrade
Change in Accounts Receivable
2.52.2-5.88--
Upgrade
Change in Accounts Payable
-1.80.99-2.815.29-0.72
Upgrade
Change in Unearned Revenue
-19.83-119.81139.98--
Upgrade
Change in Income Taxes
-0.67-3.364.02--
Upgrade
Change in Other Net Operating Assets
14.991.121-16.4-2.71
Upgrade
Operating Cash Flow
-128.51-41.56139.8-93.79-50.86
Upgrade
Capital Expenditures
-1.04-3.16-5.61-2.89-4.58
Upgrade
Investment in Securities
117.85-24.64-132.78-145.76-
Upgrade
Investing Cash Flow
116.81-27.8-138.4-148.65-4.58
Upgrade
Issuance of Common Stock
0.89102.9621.040.48191.63
Upgrade
Financing Cash Flow
0.89102.9621.040.48307.46
Upgrade
Net Cash Flow
-10.8233.6122.45-241.96252.02
Upgrade
Free Cash Flow
-129.55-44.72134.19-96.67-55.44
Upgrade
Free Cash Flow Margin
-509.63%-21.21%104.01%--
Upgrade
Free Cash Flow Per Share
-3.13-1.154.06-3.09-8.85
Upgrade
Cash Income Tax Paid
1.74.6214.72--
Upgrade
Levered Free Cash Flow
-76.96-73.29149.04-58.56-36.26
Upgrade
Unlevered Free Cash Flow
-76.96-73.29149.04-58.56-36.26
Upgrade
Change in Working Capital
-4.8-118.85136.32-11.11-3.42
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.